Search

everythinglearnresearchcommunity

for

Search:↓

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Using platelet-rich plasma, basic fibroblast growth factor, and minoxidil together significantly increases hair count and growth rate in people with hair loss.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Dog hair grows back in about 14 weeks after being clipped for surgery, and the season doesn't really affect this growth rate.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Weight loss can cause temporary hair loss, especially in women and older adults.

Francisco Camacho Martinez has made significant contributions to skin and sexually transmitted diseases, developed surgical techniques, but is concerned about patient survival rates and over-specialization in dermatology.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 may cause temporary hair loss in some people.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Monocytes might be linked to hair loss after COVID-19.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.

"Alpenta" effectively reduces hair loss and improves hair growth in women with telogen effluvium.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

COVID-19 may cause a common type of hair loss called telogen effluvium.

The oral supplement improved hair loss in patients with telogen effluvium.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Cudrania tricuspidata and Sargassum fusiforme extracts improved hair growth in mice by affecting growth-related genes.